Exploring the therapeutic potential of biosynthetic enzymes in cancer treatment: Innovations and implications

Afeeza Klg1, Boopathy Priyadharshini1, Suresh Vasugi1

  • 1Department of Physiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, Tamil Nadu, India.

Insights

Microbial enzymes offer a promising alternative to traditional cancer treatments, addressing issues like drug accessibility and resistance. These natural compounds show potential for inhibiting tumor growth with fewer side effects.

Area of Science:

  • Biochemistry
  • Oncology
  • Biotechnology

Background:

  • Cancer presents significant global health challenges, including treatment accessibility, high toxicity, and therapy resistance.
  • Current cancer therapies often have limitations, necessitating the exploration of novel therapeutic strategies.
  • Microbial enzymes are emerging as a viable alternative due to their potential anti-cancer mechanisms.

Purpose of the Study:

  • To highlight the critical role of microbial enzymes in combating cancer.
  • To review the mechanisms by which microbial enzymes inhibit tumor and cancer cell growth.
  • To provide a scientific roadmap for researchers and stakeholders on the therapeutic potential of microbial enzymes in cancer treatment.

Main Methods:

  • Comprehensive literature review of studies on microbial enzymes and their anti-cancer properties.
  • Analysis of various mechanisms employed by microbial enzymes to inhibit cancer cell proliferation.
  • Synthesis of information regarding the therapeutic potential and challenges of using microbial enzymes in oncology.

Main Results:

  • Microbial enzymes demonstrate diverse mechanisms for inhibiting uncontrolled tumor cell growth.
  • These enzymes show potential for developing effective and sustainable cancer therapies.
  • The use of microbial enzymes may lead to personalized cancer treatments with reduced side effects.

Conclusions:

  • Microbial enzymes represent a significant area of research for novel cancer therapeutics.
  • Further investigation into microbial enzymes can pave the way for more effective and targeted cancer treatments.
  • The development of enzyme-based therapies offers hope for overcoming current limitations in cancer care.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.3K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338